BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cinek O, Kramna L, Mazankova K, Odeh R, Alassaf A, Ibekwe MU, Ahmadov G, Elmahi BME, Mekki H, Lebl J. The bacteriome at the onset of type 1 diabetes: A study from four geographically distant African and Asian countries. Diabetes Res Clin Pract. 2018;144:51-62. [PMID: 30121305 DOI: 10.1016/j.diabres.2018.08.010] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
Number Citing Articles
1 Islam MZ, Tran M, Xu T, Tierney BT, Patel C, Kostic AD. Reproducible and opposing gut microbiome signatures distinguish autoimmune diseases and cancers: a systematic review and meta-analysis. Microbiome 2022;10:218. [PMID: 36482486 DOI: 10.1186/s40168-022-01373-1] [Reference Citation Analysis]
2 Alka Ahuja, Saraswathy Mp, Nandakumar S, Prakash F A, Kn G, Um D. Role of the Gut Microbiome in Diabetes and Cardiovascular Diseases Including Restoration and Targeting Approaches- A Review. Drug Metab Bioanal Lett 2022;15:133-49. [PMID: 36508273 DOI: 10.2174/2949681015666220615120300] [Reference Citation Analysis]
3 Ye J, Wu Z, Zhao Y, Zhang S, Liu W, Su Y. Role of gut microbiota in the pathogenesis and treatment of diabetes mullites: Advanced research-based review. Front Microbiol 2022;13:1029890. [DOI: 10.3389/fmicb.2022.1029890] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Wang Y, Zhao J, Qin Y, Yu Z, Zhang Y, Ning X, Sun S. The Specific Alteration of Gut Microbiota in Diabetic Kidney Diseases—A Systematic Review and Meta-Analysis. Front Immunol 2022;13:908219. [DOI: 10.3389/fimmu.2022.908219] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Guo K, Huang J, Zhou Z. Host gene effects on gut microbiota in type 1 diabetes. Biochem Soc Trans 2022:BST20220004. [PMID: 35521897 DOI: 10.1042/BST20220004] [Reference Citation Analysis]
6 Abbas-Egbariya H, Haberman Y, Braun T, Hadar R, Denson L, Gal-Mor O, Amir A. Meta-analysis defines predominant shared microbial responses in various diseases and a specific inflammatory bowel disease signal. Genome Biol 2022;23:61. [PMID: 35197084 DOI: 10.1186/s13059-022-02637-7] [Reference Citation Analysis]
7 Allali I, Abotsi RE, Tow LA, Thabane L, Zar HJ, Mulder NM, Nicol MP. Human microbiota research in Africa: a systematic review reveals gaps and priorities for future research. Microbiome 2021;9:241. [PMID: 34911583 DOI: 10.1186/s40168-021-01195-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Zhao M, Xu S, Cavagnaro MJ, Zhang W, Shi J. Quantitative Analysis and Visualization of the Interaction Between Intestinal Microbiota and Type 1 Diabetes in Children Based on Multi-Databases. Front Pediatr 2021;9. [DOI: 10.3389/fped.2021.752250] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Oweda M, Tanyous JN, Hamed M, El-hadidi M. Potential probiotics for viral triggered type 2 diabetes. 2021 3rd Novel Intelligent and Leading Emerging Sciences Conference (NILES) 2021. [DOI: 10.1109/niles53778.2021.9600499] [Reference Citation Analysis]
10 Cinek O, Polackova K, Odeh R, Alassaf A, Kramná L, Ibekwe MU, Majaliwa ES, Ahmadov G, Elmahi BME, Mekki H, Oikarinen S, Lebl J, Abdullah MA. Blastocystis in the faeces of children from six distant countries: prevalence, quantity, subtypes and the relation to the gut bacteriome. Parasit Vectors 2021;14:399. [PMID: 34384477 DOI: 10.1186/s13071-021-04859-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
11 Mokhtari P, Metos J, Anandh Babu PV. Impact of type 1 diabetes on the composition and functional potential of gut microbiome in children and adolescents: possible mechanisms, current knowledge, and challenges. Gut Microbes 2021;13:1-18. [PMID: 34101547 DOI: 10.1080/19490976.2021.1926841] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
12 Lakshmanan AP, Shatat IF, Zaidan S, Jacob S, Bangarusamy DK, Al-Abduljabbar S, Al-Khalaf F, Petroviski G, Terranegra A. Bifidobacterium reduction is associated with high blood pressure in children with type 1 diabetes mellitus. Biomed Pharmacother 2021;140:111736. [PMID: 34034069 DOI: 10.1016/j.biopha.2021.111736] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
13 Yehualashet AS, Yikna BB. Microbial Ecosystem in Diabetes Mellitus: Consideration of the Gastrointestinal System. Diabetes Metab Syndr Obes 2021;14:1841-54. [PMID: 33953584 DOI: 10.2147/DMSO.S304497] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
14 Isibor PO, Akinduti PA, Aworunse OS, Oyewale JO, Oshamika O, Ugboko HU, Taiwo OS, Ahuekwe EF, Obafemi YD, Onibokun EA, Oziegbe O, Oniha MI, Olopade BK, Atolagbe OM, Adekeye BT, Ajiboye IB, Bello OA, Popoola JO, Ayanda OI, Akinnola OO, Olasehinde GI, Eni AO, Nwinyi OC, Omonhinmin CA, Oranusi SU, Obembe OO. Significance of African Diets in Biotherapeutic Modulation of the Gut Microbiome. Bioinform Biol Insights 2021;15:11779322211012697. [PMID: 33994782 DOI: 10.1177/11779322211012697] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
15 Cinek O, Kramna L, Odeh R, Alassaf A, Ibekwe MAU, Ahmadov G, Elmahi BME, Mekki H, Lebl J, Abdullah MA. Eukaryotic viruses in the fecal virome at the onset of type 1 diabetes: A study from four geographically distant African and Asian countries. Pediatr Diabetes 2021;22:558-66. [PMID: 33786936 DOI: 10.1111/pedi.13207] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
16 Bezirtzoglou E, Stavropoulou E, Kantartzi K, Tsigalou C, Voidarou C, Mitropoulou G, Prapa I, Santarmaki V, Kompoura V, Yanni AE, Antoniadou M, Varzakas T, Kourkoutas Y. Maintaining Digestive Health in Diabetes: The Role of the Gut Microbiome and the Challenge of Functional Foods. Microorganisms 2021;9:516. [PMID: 33802371 DOI: 10.3390/microorganisms9030516] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
17 Biassoni R, Di Marco E, Squillario M, Barla A, Piccolo G, Ugolotti E, Gatti C, Minuto N, Patti G, Maghnie M, d'Annunzio G. Gut Microbiota in T1DM-Onset Pediatric Patients: Machine-Learning Algorithms to Classify Microorganisms as Disease Linked. J Clin Endocrinol Metab 2020;105:dgaa407. [PMID: 32692360 DOI: 10.1210/clinem/dgaa407] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
18 Elhag DA, Kumar M, Al Khodor S. Exploring the Triple Interaction between the Host Genome, the Epigenome, and the Gut Microbiome in Type 1 Diabetes. Int J Mol Sci 2020;22:E125. [PMID: 33374418 DOI: 10.3390/ijms22010125] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
19 Wei X, Zong W, Gao Y, Peng S, Liu K, Zheng Y. Effects of the Traditional Chinese Medicine Tang Luo Ning on Intestinal Flora and Oxidative Stress in Diabetic Rats. Evid Based Complement Alternat Med 2020;2020:3452625. [PMID: 33204285 DOI: 10.1155/2020/3452625] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Zhou H, Zhao X, Sun L, Liu Y, Lv Y, Gang X, Wang G. Gut Microbiota Profile in Patients with Type 1 Diabetes Based on 16S rRNA Gene Sequencing: A Systematic Review. Dis Markers 2020;2020:3936247. [PMID: 32908614 DOI: 10.1155/2020/3936247] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
21 Yanni AE, Mitropoulou G, Prapa I, Agrogiannis G, Kostomitsopoulos N, Bezirtzoglou E, Kourkoutas Y, Karathanos VT. Functional modulation of gut microbiota in diabetic rats following dietary intervention with pistachio nuts (Pistacia vera L.). Metabol Open 2020;7:100040. [PMID: 32812934 DOI: 10.1016/j.metop.2020.100040] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
22 Afolayan AO, Adebusoye LA, Cadmus EO, Ayeni FA. Insights into the gut microbiota of Nigerian elderly with type 2 diabetes and non-diabetic elderly persons. Heliyon 2020;6:e03971. [PMID: 32490229 DOI: 10.1016/j.heliyon.2020.e03971] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
23 Fenneman AC, Rampanelli E, Yin YS, Ames J, Blaser MJ, Fliers E, Nieuwdorp M. Gut microbiota and metabolites in the pathogenesis of endocrine disease. Biochemical Society Transactions 2020;48:915-31. [DOI: 10.1042/bst20190686] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
24 Zhou H, Sun L, Zhang S, Zhao X, Gang X, Wang G. Evaluating the Causal Role of Gut Microbiota in Type 1 Diabetes and Its Possible Pathogenic Mechanisms. Front Endocrinol (Lausanne) 2020;11:125. [PMID: 32265832 DOI: 10.3389/fendo.2020.00125] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 15.0] [Reference Citation Analysis]
25 Ma Q, Li Y, Wang J, Li P, Duan Y, Dai H, An Y, Cheng L, Wang T, Wang C, Wang T, Zhao B. Investigation of gut microbiome changes in type 1 diabetic mellitus rats based on high-throughput sequencing. Biomed Pharmacother 2020;124:109873. [PMID: 31986412 DOI: 10.1016/j.biopha.2020.109873] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 19.7] [Reference Citation Analysis]
26 Jamshidi P, Hasanzadeh S, Tahvildari A, Farsi Y, Arbabi M, Mota JF, Sechi LA, Nasiri MJ. Is there any association between gut microbiota and type 1 diabetes? A systematic review. Gut Pathog 2019;11:49. [PMID: 31636716 DOI: 10.1186/s13099-019-0332-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 10.3] [Reference Citation Analysis]
27 Siljander H, Honkanen J, Knip M. Microbiome and type 1 diabetes. EBioMedicine 2019;46:512-21. [PMID: 31257149 DOI: 10.1016/j.ebiom.2019.06.031] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 16.5] [Reference Citation Analysis]
28 Cinek O, Šumník Z. Type 1 diabetes: etiology and epidemiology. Vnitr Lek 2019;65:235-247. [DOI: 10.36290/vnl.2019.041] [Reference Citation Analysis]
29 Salih M, Swar M. Inauguration of another pyramid: the Sudan Childhood Diabetes Center. Sudan J Paed 2019. [DOI: 10.24911/sjp.106-1576648349] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
30 Stapff MP. Using real world data to assess cardiovascular outcomes of two antidiabetic treatment classes. World J Diabetes 2018; 9(12): 252-257 [PMID: 30588287 DOI: 10.4239/wjd.v9.i12.252] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]